Association studies testing for risk for late-onset Alzheimer's disease with common variants in the β-amyloid precursor protein (APP)

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 144, Issue 4, 2007, Pages 469-474

  Nowotny, Petra ^a   Simcock, Xavier ^a   Bertelsen, Sarah ^a   Hinrichs, Anthony L ^a   Kauwe, John S K ^a   Mayo, Kevin ^a   Smemo, Scott ^a   Morris, John C ^a   Goate, Alison ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

amyloid precursor protein (APP); Alzheimer's disease (AD); Association analysis; Single nucleotide polymorphism (SNP)

Indexed keywords

AMYLOID PRECURSOR PROTEIN;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC EPIDEMIOLOGY; GENETIC RISK; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SINGLE NUCLEOTIDE POLYMORPHISM;

AGE OF ONSET; AGED; AGED, 80 AND OVER; ALLELES; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; APOLIPOPROTEINS E; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; UNITED STATES;

EID: 34250819923     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.30485     Document Type: Article

References (37)

1. Athan ES, Lee JH, Arriaga A, Mayeux RP, Tycko B. 2002. Polymorphisms in the promoter of the human APP gene: Functional evaluation and allele frequencies in Alzheimer disease. Arch Neurol 59(11):1793-1799.
2. Balciuniene J, Emilsson L, Oreland L, Pettersson U, Jazin E. 2002. Investigation of the functional effect of monoamine oxidase polymorphisms in human brain. Hum Genet 110(1):1-7.
3. Blacker D, Bertram L, Saunders AJ, Moscarillo TJ, Albert MS, Wiener H, Perry RT, Collins JS, Harrell LE, Go RC, et al. 2003. Results of a high-resolution genome screen of 437 Alzheimer's disease families. Hum Mol Genet 12(1):23-32.
4. Cacchione PZ, Powlishta KK, Grant EA, Buckles VD, Morris JC. 2003. Accuracy of collateral source reports in very mild to mild dementia of the Alzheimer type. J Am Geriatr Soc 51(6):819-823.
5. Chiba-Falek O, Nussbaum RL. 2003. Regulation of alpha-synuclein expression: Implications for Parkinson's disease. Cold Spring Harb Symp Quant Biol 68:409-415.
6. Clement M, Posada D, Crandall KA. 2000. TCS: A computer program to estimate gene genealogies. Mol Ecol 9:1657-1659.
7. Dudbridge F. 2003. Pedigree disequilibrium tests for multilocus haplotypes. Genet Epidemiol 25(2):115-121.
8. Farrer M, Maraganore DM, Lockhart P, Singleton A, Lesnick TG, de Andrade M, West A, de Silva R, Hardy J, Hernandez D. 2001. Alpha-Synuclein gene haplotypes are associated with Parkinson's disease. Hum Mol Genet 10(17):1847-1851.
9. Goate A, Chartier-Harlin MC, Mullan M, Brown J, Crawford F, Fidani L, Giuffra L, Haynes A, Irving N, James L, et al. 1991. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 349(6311):704-706.
10. Grupe A, Li Y, Rowland C, Nowotny P, Hinrichs AL, Smemo S, Kauwe JS, Maxwell TJ, Cherny S, Doil L et al. 2006. A scan of chromosome 10 identifies a novel locus showing strong association with late-onset Alzheimer disease. Am J Hum Genet 78(1):78-88.
11. Herzig MC, Winkler DT, Burgermeister P, Pfeifer M, Kohler E, Schmidt SD, Danner S, Abramowski D, Sturchler-Pierrat C, Burki K et al. 2004. Abeta is targeted to the vasculature in a mouse model of hereditary cerebral hemorrhage with amyloidosis. Nat Neurosci 7(9):954-960.
12. Hyman BT. 1992. Down syndrome and Alzheimer disease. Prog Clin Biol Res 379:123-142.
13. Kida E, Choi-Miura NH, Wisniewski KE. 1995. Deposition of apolipoproteins E and J in senile plaques is topographically determined in both Alzheimer's disease and Down's syndrome brain. Brain Res 685(1-2):211-216.
14. Knoblauch H, Bauerfeind A, Krahenbuhl C, Daury A, Rohde K, Bejanin S, Essioux L, Schuster H, Luft FC, Reich JG. 2002. Common haplotypes in five genes influence genetic variance of LDL and HDL cholesterol in the general population. Hum Mol Genet 11(12):1477-1485.
15. Lahiri DK, Ge YW, Maloney B, Wavrant-De Vrieze F, Hardy J. 2005. Characterization of two APP gene promoter polymorphisms that appear to influence risk of late-onset Alzheimer's disease. Neurobiol Aging 26(10):1329-1341.
16. Li L, Perry R, Wu J, Pham D, Ohman T, Harrell LE, Go RC, Fukuchi K. 1998. Polymorphic tetranucleotide repeat site within intron 7 of the beta-amyloid precursor protein gene and its lack of association with Alzheimer's disease. Hum Genet 103(1):86-89.
17. Li Y, Nowotny P, Holmans P, Smemo S, Kauwe JS, Hinrichs AL, Tacey K, Doil L, van Luchene R, Garcia V et al. 2004. Association of late-onset Alzheimer's disease with genetic variation in multiple members of the GAPD gene family. Proc Natl Acad Sci USA 101(44):15688-15693.
18. Morris JC, Ernesto C, Schafer K, Coats M, Leon S, Sano M, Thai LJ, Woodbury P. 1997. Clinical dementia rating training and reliability in multicenter studies: The Alzheimer's Disease Cooperative Study experience. Neurology 48(6):1508-1510.
19. Myers A, Wavrant De-Vrieze F, Holmans P, Hamshere M, Crook R, Compton D, Marshall H, Meyer D, Shears S, Booth J et al. 2002. Full genome screen for Alzheimer disease: Stage II analysis. Am J Med Genet 114(2):235-244.
20. Nowotny P, Hinrichs AL, Smemo S, Kauwe JS, Maxwell T, Holmans P, Hamshere M, Turic D, Jehu L, Hollingworth P et al. 2005. Association studies between risk for late-onset Alzheimer's disease and variants in insulin degrading enzyme. Am J Med Genet B Neuropsychiatr Genet 136(1):62-68.
21. Olson JM, Goddard KA, Dudek DM. 2002. A second locus for very-late-onset Alzheimer disease: A genome scan reveals linkage to 20p and epistasis between 20p and the amyloid precursor protein region. Am J Hum Genet 71(1):154-161.
22. Pastor P, Goate AM. 2004. Molecular genetics of Alzheimer's disease. Curr Psychiatry Rep 6(2):125-133.
23. Prasher VP, Farrer MJ, Kessling AM, Fisher EM, West RJ, Barber PC, Butler AC. 1998. Molecular mapping of Alzheimer-type dementia in Down's syndrome. Ann Neurol 43(3):380-383.
24. Prusiner SB. 1998. Prions. Proc Natl Acad Sci USA 95(23):13363-13383.
25. Rovelet-Lecrax A, Hannequin D, Raux G, Le Meur N, Laquerriere A, Vital A, Dumanchin C, Feuillette S, Brice A, Vercelletto M et al. 2006. APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy. Nat Genet 38(1):24-26.
26. Rumble B, Retallack R, Hilbich C, Simms G, Multhaup G, Martins R, Hockey A, Montgomery P, Beyreuther K, Masters CL. 1989. Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease. N Engl J Med 320(22):1446-1452.
27. Schupf N, Patel B, Silverman W, Zigman WB, Zhong N, Tycko B, Mehta PD, Mayeux R. 2001. Elevated plasma amyloid beta-peptide 1-42 and onset of dementia in adults with Down syndrome. Neurosci Lett 301(3):199-203.
28. Singleton A, Myers A, Hardy J. 2004. The law of mass action applied to neurodegenerative disease: A hypothesis concerning the etiology and pathogenesis of complex diseases. Hum Mol Genet 13(Spec No 1):R123-R126.
29. Stephens M, Donnelly P. 2003. A comparison of bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet 73:1162-1169.
30. Stephens M, Smith NJ, Donnelly P. 2001. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 68:978-989.
31. Templeton AR, Weiss KM, Nickerson DA, Boerwinkle E, Sing CF. 2000. Cladistic structure within the human Lipoprotein lipase gene and its implications for phenotypic association studies. Genetics 156(3):1259-1275.
32. Templeton AR, Maxwell T, Posada D, Stengard JH, Boerwinkle E, Sing CF. 2005. Tree scanning: A method for using haplotype trees in phenotype/ genotype association studies. Genetics 169:441-453.
33. Theuns J, Brouwers N, Engelborghs S, Sleegers K, Bogaerts V, Corsmit E, De Pooter T, van Duijn CM, De Deyn PP, Van Broeckhoven C. 2006. Promoter mutations that increase amyloid precursor-protein expression are associated with Alzheimer disease. Am J Hum Genet 78(6):936-946.
34. Van Eerdewegh P, Little RD, Dupuis J, Del Mastro RG, Falls K, Simon J, Torrey D, Pandit S, McKenny J, Braunschweiger K et al. 2002. Association of the ADAM33 gene with asthma and bronchial hyperresponsiveness. Nature 418(6896):426-430.
35. Wavrant-De Vrieze F, Crook R, Holmans P, Kehoe P, Owen MJ, Williams J, Roehl K, Laliiri DK, Shears S, Booth J et al. 1999. Genetic variability at the amyloid-beta precursor protein locus may contribute to the risk of late-onset Alzheimer's disease. Neurosci Lett 269(2):67-70.
36. Wisniewski KE, Wisniewski HM, Wen GY. 1985. Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome. Ann Neurol 17(3):278-282.
37. Zigman WB, Schupf N, Sersen E, Silverman W. 1996. Prevalence of dementia in adults with and without Down syndrome. Am J Ment Retard 100(4):403-412.